Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Nazha

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Blood|June 20, 2013
Measuring the symptom burden associated with the treatment of chronic myeloid leukemiaLoretta A Williams, Araceli G Garcia Gonzalez, Patricia Ault, et al.
American Journal of Hematology|December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndromePaolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Haematologica|March 4, 2017
Molecular features of early onset adult myelodysplastic syndromeCassandra M Hirsch, Bartlomiej P Przychodzen, Tomas Radivoyevitch, et al.
Frontiers in Oncology|September 14, 2013
The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid LeukemiaAziz Nazha, Carlos Bueso-Ramos, Eli Estey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et alRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Journal of Hematology & Oncology|March 10, 2023
Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantationJing Dong, Christopher Staffi Buradagunta, Tao Zhang, et al.
Leukemia & Lymphoma|September 14, 2020
Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplantBinod Dhakal, Tao Wang, Michelle Kuxhausen, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2015
Characteristics of Sweet Syndrome in patients with acute myeloid leukemiaSyed M Kazmi, Naveen Pemmaraju, Keyur P Patel, et al.
Blood|September 13, 2017
Origins of myelodysplastic syndromes after aplastic anemiaEiju Negoro, Yasunobu Nagata, Michael J Clemente, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Blood|June 20, 2013
Measuring the symptom burden associated with the treatment of chronic myeloid leukemiaLoretta A Williams, Araceli G Garcia Gonzalez, Patricia Ault, et al.
American Journal of Hematology|December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndromePaolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Haematologica|March 4, 2017
Molecular features of early onset adult myelodysplastic syndromeCassandra M Hirsch, Bartlomiej P Przychodzen, Tomas Radivoyevitch, et al.
Frontiers in Oncology|September 14, 2013
The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid LeukemiaAziz Nazha, Carlos Bueso-Ramos, Eli Estey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et alRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.
Journal of Hematology & Oncology|March 10, 2023
Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantationJing Dong, Christopher Staffi Buradagunta, Tao Zhang, et al.
Leukemia & Lymphoma|September 14, 2020
Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplantBinod Dhakal, Tao Wang, Michelle Kuxhausen, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2015
Characteristics of Sweet Syndrome in patients with acute myeloid leukemiaSyed M Kazmi, Naveen Pemmaraju, Keyur P Patel, et al.
Blood|September 13, 2017
Origins of myelodysplastic syndromes after aplastic anemiaEiju Negoro, Yasunobu Nagata, Michael J Clemente, et al.
Pageof 13